Menu
Back to Journals » OncoTargets and Therapy » Volume 9
Original Research
LXY6090 – a novel manassantin A derivative – limits breast cancer growth through hypoxia-inducible factor-1 inhibition
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 7,010 | Dovepress* | 6,521+ | 1,242 | 7,763 | |
| PubMed Central* | 489 | 162 | 651 | ||
| Totals | 7,010 | 1,404 | 8,414 | ||
|
*Since 24 June 2016 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 10 | 0 | 0 | 0 | 3 | 7 |
View citations on PubMed Central and Google Scholar